These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9713206)

  • 1. [A long-term study of the visual fields in patients treated with betaxolol and timolol].
    Flammer J; Collignon-Brach J; Demailly P; Graves SA
    Oftalmologia; 1998; 42(1):77-82; discussion 82-3. PubMed ID: 9713206
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
    Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
    Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
    Dorigo MT; Cerin O; Fracasso G; Altafini R
    Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up of treated patients with glaucoma using resolution perimetry.
    Martin L; Wanger P
    J Glaucoma; 1998 Feb; 7(1):22-6. PubMed ID: 9493111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure or progression?
    Burnstein Y; Robin AL
    Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
    Messmer C; Flammer J; Stümpfig D
    Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma.
    Drance SM
    J Glaucoma; 1998 Aug; 7(4):247-52. PubMed ID: 9713782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database.
    Rahman MQ; Abeysinghe SS; Kelly S; Roskell NS; Shannon PR; Abdlseaed AA; Montgomery DM
    Br J Ophthalmol; 2011 Jul; 95(7):966-70. PubMed ID: 21258080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
    Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
    Arzneimittelforschung; 2006; 56(12):820-5. PubMed ID: 17260669
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of long-term drift in timolol's effectiveness in patients with ocular hypertension.
    Bengtsson B; Heijl A
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2839-42. PubMed ID: 11687526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol.
    Nino M; Napolitano M; Scalvenzi M
    Contact Dermatitis; 2010 May; 62(5):319-20. PubMed ID: 20536484
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
    Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
    Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the betaxolol versus placebo treatment trial in ocular hypertension.
    Kamal D; Garway-Heath D; Ruben S; O'Sullivan F; Bunce C; Viswanathan A; Franks W; Hitchings R
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):196-203. PubMed ID: 12644943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Frishman WH; Fuksbrumer MS; Tannenbaum M
    J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.